Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multicompartment urea kinetics in well-dialyzed children.

A Sharma1, P Espinosa, L Bell

  • 1Division of Pediatric Nephrology, McGill University/Montreal Children's Hospital, Montreal, Quebec, Canada. asharm@po-box.mcgill.ca

Kidney International
|October 24, 2000
PubMed
Summary

A new variable volume, two-pool (VVDP) model accurately estimates hemodialysis (HD) dose (K(d)t/V) and urea distribution volume, improving pediatric nephrology care. This model clarifies the precise HD dose required for optimal growth in children undergoing treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CD28 ligation prevents bacterial toxin-induced septic shock in mice by inducing IL-10 expression.

Journal of immunology (Baltimore, Md. : 1950)·1997
Same author

MR imaging of tubercular spinal arachnoiditis.

AJR. American journal of roentgenology·1997
Same author

Interactions between transvenous nonthoracotomy cardioverter defibrillator systems and permanent transvenous endocardial pacemakers.

Pacing and clinical electrophysiology : PACE·1997
Same author

Role of the carboxyl-terminal region of Porphyromonas gingivalis fimbrillin in binding to salivary proteins.

Infection and immunity·1997
Same author

Phenethyl isothiocyanate modulates clastogenicity of mitomycin C and cyclophosphamide in vivo.

Mutation research·1996
Same author

Expression of functional Porphyromonas gingivalis fimbrillin polypeptide domains on the surface of Streptococcus gordonii.

Applied and environmental microbiology·1996

Area of Science:

  • Pediatric Nephrology
  • Renal Replacement Therapy
  • Biomedical Modeling

Background:

  • Hemodialysis (HD) dose estimation is crucial for pediatric patients, particularly for achieving catch-up growth.
  • Existing models like variable-volume single-pool (VVSP) and fixed-volume two-pool (FVDP) inaccurately estimate HD dose (K(d)t/V) due to urea rebound.
  • Accurate K(d)t/V is essential for monitoring treatment adequacy and ensuring patient outcomes.

Purpose of the Study:

  • To develop and validate a novel variable volume, two-pool (VVDP) model for more accurate hemodialysis dose estimation.
  • To compare the performance of the VVDP model against existing VVSP and FVDP models.
  • To re-evaluate the hemodialysis dose in a cohort of well-dialyzed pediatric patients using the validated VVDP model.

Main Methods:

Related Experiment Videos

  • Developed an approximate perturbation solution (WKB method) for a variable volume, two-pool (VVDP) model.
  • Validated the VVDP model by comparing its parameter estimates with equilibrated kinetic studies (N=17).
  • Re-analyzed 292 kinetic studies from a previously characterized cohort of pediatric patients.

Main Results:

  • The VVDP model demonstrated significantly lower mean errors in K(d)t/V (0.06 +/- 0.07) and urea distribution volume (-2.2 +/- 3.6%) compared to VVSP and FVDP models.
  • Reproducibility of sequential studies using the VVDP model was confirmed with a coefficient of variation <= 5%.
  • In the re-analyzed cohort, the VVDP model yielded a K(d)t/V of 1.76 +/- 0.33, which was significantly different from the VVSP model's estimate (1.91 +/- 0.35).

Conclusions:

  • The developed VVDP model provides reliable estimates of K(d)t/V and other kinetic parameters using standard post-treatment blood urea nitrogen sampling.
  • This model offers a more accurate assessment of hemodialysis dose in pediatric patients.
  • The findings clarify the specific hemodialysis dose necessary to support normal growth in children undergoing renal replacement therapy.